Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

The University of Osaka and Kyoto University have established funds to support the research fields of Nobel laureates Shimon ...

Qihan Biotech, a clinical-stage biotechnology company developing off-the-shelf cell therapies for autoimmune diseases and cancer, including allogeneic CAR-T and in vivo CAR-T therapies, presented an ...

Measuring the lymphocytes—white blood cells that fight infection—in a patient's blood can be used to predict outcomes in ...

Cellarity, a clinical-stage biotechnology company developing Cell State-Correcting therapies through integrated multi-omics and AI modeling, today announced the presentation of new preclinical data on ...

In a recent preclinical study, researchers from The University of Texas MD Anderson Cancer Center developed an antibody ...

The axolotl, a type of salamander that stays in the tadpole form throughout its life, is a master of regeneration. Axolotls ...

Studies have shown EBV has links with a variety of illnesses, including mononucleosis (also known as mono or ‘the kissing disease’), multiple sclerosis, long Covid, and systemic lupus erythematosus.

STEMCELL Technologies and Immudex have announced the launch of a new protocol that combines the power of the EasySep Release positive selection platform with Immudex's Dextramer® reagents, enabling ...

Despite being among the great scientific breakthroughs of all time, vaccines are under fire as top US government officials ...

While participating in a two-day India-EMBO Lecture Course on ‘Cell-Autonomous Defence and Innate Immunity’ held at CCMB, ...

The post After missile strike leveled her lab, Israeli scientist named in prestigious Nature’s 10 appeared first on The Times ...